207 related articles for article (PubMed ID: 6587517)
1. [Cross reactions of HLA A and B antigens in 63 patients with rheumatoid arthritis].
Dreyfus P; Geay D; Cambon H; Daupleix D
Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):197-202. PubMed ID: 6587517
[TBL] [Abstract][Full Text] [Related]
2. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
[TBL] [Abstract][Full Text] [Related]
3. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
Dequeker J; Van Wanghe P; Verdickt W
J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility antigens (A, B, C, and DR) in Arabs with rheumatoid arthritis.
Sattar MA; al-Saffar M; Guindi RT; Sugathan TN; White AG; Behbehani K
Dis Markers; 1990; 8(1):11-5. PubMed ID: 2311344
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
[TBL] [Abstract][Full Text] [Related]
7. HLA and rheumatoid arthritis: susceptibility or severity?
Jaraquemada D; Ollier W; Awad J; Young A; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):43-53. PubMed ID: 3482987
[TBL] [Abstract][Full Text] [Related]
8. Antibody to rheumatoid arthritis associated nuclear antigen (RANA) in familial rheumatoid arthritis.
Bell DA; Alspaugh MA
J Rheumatol; 1984 Jun; 11(3):277-81. PubMed ID: 6610751
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
[TBL] [Abstract][Full Text] [Related]
12. HLA studies in familial and sporadic rheumatoid arthritis.
Khan MA; Khan MK
Dis Markers; 1986 Jun; 4(1-2):67-76. PubMed ID: 3482988
[TBL] [Abstract][Full Text] [Related]
13. Seronegative rheumatoid arthritis: a clinical study with HLA typing.
Kaarela K; Alekberova Z; Lehtinen K; Puolakka K; Koskimies S; Nassonova V; Pospelov L
J Rheumatol; 1990 Sep; 17(9):1125-9. PubMed ID: 2290153
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA alleles and clinical features in patients with synovitis of recent onset.
El-Gabalawy HS; Goldbach-Mansky R; Smith D; Arayssi T; Bale S; Gulko P; Yarboro C; Wilder RL; Klippel JH; Schumacher HR
Arthritis Rheum; 1999 Aug; 42(8):1696-705. PubMed ID: 10446870
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis.
Gran JT; Husby G; Thorsby E
J Rheumatol; 1984 Apr; 11(2):136-40. PubMed ID: 6610047
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.
Scherak O; Smolen JS; Mayr WR
J Rheumatol; 1980; 7(1):9-12. PubMed ID: 6965505
[TBL] [Abstract][Full Text] [Related]
18. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
Darke C; Wagner MM; Nuki G; Dyer PA
Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
[TBL] [Abstract][Full Text] [Related]
19. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
